In melanoma, its expression is activated by Wnt/β-catenin and MITF [39], and as expected, ICG-001 treatment suppressed ABCB5 mRNA as well as expression of ABCB5 immunoreactive isoforms in both our VemR models. This evidence concerns the gene ABCB5 and melanoma.